Maximum quantity allowed is 999
CAS RN: 112529-15-4 | Product Number: P1901
Pioglitazone Hydrochloride

Purity: >98.0%(HPLC)(N)
- 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹8,400.00
|
1 | 25 |
|
25G |
₹16,400.00
|
1 | 28 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | P1901 |
Purity / Analysis Method ![]() |
>98.0%(HPLC)(N) |
Molecular Formula / Molecular Weight | C__1__9H__2__0N__2O__3S·HCl = 392.90 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 112529-15-4 |
Related CAS RN ![]() |
111025-46-8 |
Reaxys Registry Number | 3579575 |
PubChem Substance ID | 125307574 |
SDBS (AIST Spectral DB) | 52915 |
Merck Index (14) | 7452 |
MDL Number | MFCD04975446 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(with Total Nitrogen) | min. 98.0 % |
Melting point | 190.0 to 197.0 °C |
Melting Point | 191 °C |
References
- An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
- Synthesis and Biological Activity of Metabolites of the Antidiabetic, Antihyperglycemic Agent Pioglitazone
- Pioglitazone (a review)
- Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
- Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
- Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease
- Quantitative determination of pioglitazone in human serum by direct-injection high-performance liquid chromatography mass spectrometry and its application to a bioequivalence study
- インスリン抵抗性改善薬ピオグリタゾンの創製 (a review)
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.